Paper41535649
Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer.
Zhang L and 5 others. Discov Oncol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer. Papers, record 41535649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535649
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 82271678 | the National Natural Science Foundation of China | PubMed | ||
| No. 2022J02058 | the Natural Science Foundation of Fujian Province | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 2 | 39174693 | Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/39174693 | PubMed |
| 3 | 36420154 | Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/36420154 | PubMed |
| 4 | 32793281 | Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer. | Front Genet | 2020 | https://conductscience.org/library/papers/32793281 | PubMed |
| 5 | 36273006 | Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma. | Nat Commun | 2022 | https://conductscience.org/library/papers/36273006 | PubMed |
| 6 | 36158685 | Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36158685 | PubMed |
| 7 | 29344893 | Profiling Tumor Infiltrating Immune Cells with CIBERSORT. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29344893 | PubMed |
| 8 | 33429363 | Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/33429363 | PubMed |
| 9 | 24113773 | Inferring tumour purity and stromal and immune cell admixture from expression data. | Nat Commun | 2013 | https://conductscience.org/library/papers/24113773 | PubMed |
| 10 | 29625050 | Oncogenic Signaling Pathways in The Cancer Genome Atlas. | Cell | 2018 | https://conductscience.org/library/papers/29625050 | PubMed |
| 11 | 34724589 | Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. | Gastric Cancer | 2022 | https://conductscience.org/library/papers/34724589 | PubMed |
| 12 | 36878570 | Immunotherapy in endometrial cancer. | Int J Gynecol Cancer | 2023 | https://conductscience.org/library/papers/36878570 | PubMed |
| 13 | 38596689 | Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cells. | Front Immunol | 2024 | https://conductscience.org/library/papers/38596689 | PubMed |
| 14 | 34502029 | Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502029 | PubMed |
| 15 | 37491281 | RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. | Mil Med Res | 2023 | https://conductscience.org/library/papers/37491281 | PubMed |
| 16 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 17 | 27197262 | Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment. | Cancer Res | 2016 | https://conductscience.org/library/papers/27197262 | PubMed |
| 18 | 25605792 | limma powers differential expression analyses for RNA-sequencing and microarray studies. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25605792 | PubMed |
| 19 | 31740819 | Fast, sensitive and accurate integration of single-cell data with Harmony. | Nat Methods | 2019 | https://conductscience.org/library/papers/31740819 | PubMed |
| 20 | 36282174 | Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. | Elife | 2022 | https://conductscience.org/library/papers/36282174 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42418064 | Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42418064 |
Source PubMed
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK16 | 5127 | PubTator's text mining | https://conductscience.org/library/genes/5127 | NCBI Gene |
| CIT | 11113 | PubTator's text mining | https://conductscience.org/library/genes/11113 | NCBI Gene |
| HAPLN1 | 1404 | PubTator's text mining | https://conductscience.org/library/genes/1404 | NCBI Gene |
| LRRN4CL | 221091 | PubTator's text mining | https://conductscience.org/library/genes/221091 | NCBI Gene |
| LTB | 4050 | PubTator's text mining | https://conductscience.org/library/genes/4050 | NCBI Gene |
| RARRES2 | 5919 | PubTator's text mining | https://conductscience.org/library/genes/5919 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41535649
GET https://conductscience.org/api/papers/v1/41535649/references?page=2